ArticlePloS one2014

Similar prevalence of low-abundance drug-resistant variants in treatment-naive patients with genotype 1a and 1b hepatitis C virus infections as determined by ultradeep pyrosequencing.

Severine Margeridon-Thermet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.